Soleus Capital Management’s OrthoPediatrics KIDS Stock Holding History

Soleus Capital Management’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14M	Buy	732,144 +116,697	+19%	+$2.03M	0.48%	49
2026 Q1	$9.77M	Buy	615,447 +90,000	+17%	+$1.57M	0.4%	50
2025 Q4	$9.33M	Buy	525,447 +397,447	+311%	+$6.96M	0.34%	51
2025 Q3	$2.37M	Buy	128,000 +83,000	+184%	+$1.71M	0.12%	72
2025 Q2	$967K	Hold	45,000	–	–	0.06%	84
2025 Q1	$1.11M	Buy	+45,000	New	+$1.11M	0.08%	71
2024 Q4	–	Sell	-288,945	Closed	-$7.83M	–	96
2024 Q3	$7.83M	Sell	288,945 -20,555	-7%	-$623K	0.61%	43
2024 Q2	$8.9M	Buy	+309,500	New	+$9.49M	0.79%	42
2023 Q1	–	Sell	-7,471	Closed	-$297K	–	88
2022 Q4	$297K	Buy	+7,471	New	+$311K	0.04%	71

Other funds holding KIDS

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Soleus Capital Management's KIDS Position: Q2 2026 in Review

Soleus Capital Management increased its OrthoPediatrics (KIDS) stake by 19% in Q2 2026, buying an estimated $2.03M and bringing the position to 732,144 shares worth $14M. The position accounts for 0.48% of the portfolio, ranked #49.

Soleus Capital Management first reported a position in KIDS in Q4 2022 and has held it in 9 quarters since. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

Soleus Capital Management held 732,144 shares of OrthoPediatrics worth $14M as of Q2 2026.
Soleus Capital Management bought 116,697 OrthoPediatrics shares in Q2 2026, an estimated $2.03M.
OrthoPediatrics made up 0.48% of Soleus Capital Management's portfolio in Q2 2026, its #49 holding.
Soleus Capital Management first reported a position in OrthoPediatrics in Q4 2022 and has held it in 9 quarters since.
120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.